focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBCN.L Regulatory News (BCN)

  • There is currently no data for BCN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

2 Sep 2021 09:36

RNS Number : 5338K
Citigroup Global Markets Limited
02 September 2021
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whoserelevant securities this form relates:Use a separate form for each offeror/offeree

Bacanora Lithium plc

(c) Name of the party to the offer with which exemptprincipal trader is connected:

Bacanora Lithium plc

(d) Date dealing undertaken:

1 September 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received(GBP)

Lowest price per unit paid/received(GBP)

10p ordinary

Purchase

1,126

0.6610

0.6610

10p ordinary

Sale

1,126

0.6610

0.6610

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealinge.g. opening/closing along/short position,increasing/reducing along/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing,selling,varying etc.

Number of securities towhich option relates

Exercise price per unit

Type e.g. American,European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number ofsecurities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

 

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit(if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,formal or informal, relating to relevant securities which may be an inducement to dealor refrain from dealing entered into by the exempt principal trader making thedisclosure and any party to the offer or any person acting in concert witha party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, betweenthe exempt principal trader making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

2 September 2021

Contact name:

Damian Flanagan

Telephone number:

+44 (28) 9040-9676

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFZGGLRZKGMZG
Date   Source Headline
4th Sep 20179:34 amRNSHolding(s) in Company
24th Aug 20177:00 amRNSSonora Lithium Project Update
14th Aug 20175:30 pmRNSHolding(s) in Company
31st Jul 20172:15 pmRNSHolding(s) in Company
9th Jun 20177:00 amRNSFormal Appointment of Non-Executive Directors
5th Jun 20179:12 amRNSHolding(s) in Company
1st Jun 201710:15 amRNSHolding(s) in Company
31st May 20174:15 pmRNSFinancial Statements
31st May 20174:15 pmRNSMD&A
25th May 20177:00 amRNSIssue of Equity
15th May 20179:15 amRNSHolding(s) in Company
15th May 20177:00 amRNSBoard Changes and Operations Update
8th May 20172:23 pmRNSHolding(s) in Company
8th May 201712:52 pmRNSHolding(s) in Company
2nd May 20177:00 amRNSCompletion of Hanwa Equity Placing
10th Apr 20177:00 amRNSOff-Take Agreement & Strategic Partnership
21st Mar 20177:00 amRNSDirector/PDMR Shareholding
17th Mar 20172:10 pmRNSDirector/PDMR Shareholding
15th Mar 201711:00 amRNSTransaction Notification
3rd Mar 20177:00 amRNSGrant of Options
28th Feb 20177:00 amRNSInterim Results
21st Feb 20177:00 amRNSAcquires 50% Interest in German Lithium Asset
6th Feb 20177:00 amRNSIssue of Equity
26th Jan 20177:00 amRNSBoard Change
20th Dec 20167:00 amRNSOff-take Negotiations and Project Update
24th Nov 20167:00 amRNSBoard Changes and Corporate Update
23rd Nov 20167:00 amRNSTransfer of Shares
18th Nov 20168:50 amRNSQ1 Results
11th Nov 20167:00 amRNSSonora Project Update
28th Oct 20162:00 pmRNSDirectorate Change
27th Oct 20167:00 amRNSFinal Results
21st Oct 20163:36 pmRNSHolding(s) in Company
18th Oct 20167:00 amRNSBoard Appointment
6th Oct 20167:00 amRNSOperations Update
5th Oct 20163:17 pmRNSWarrant Exercise
30th Sep 20167:00 amRNSRebuttal of Proposed Merger
29th Sep 20167:00 amRNSResult of AGM & GM
20th Sep 20164:45 pmRNSHolding(s) in Company
8th Sep 201610:00 amRNSHolding(s) in Company
5th Sep 20168:00 amRNSSchedule 1 update - Bacanora Lithium Plc
1st Sep 20167:00 amRNSPosting of Supplement and Notice of GM
18th Aug 201611:24 amRNSSchedule 1 update - Bacanora Lithium Plc
17th Aug 20167:00 amRNSAppointment of Broker and Corporate Adviser
12th Aug 20161:00 pmRNSSchedule 1 update - Bacanora Lithium Plc
11th Aug 20168:01 amRNSPostponement of Annual and General Meeting
10th Aug 20169:00 amRNSPostponement of Annual and General Meeting
5th Aug 20163:00 pmRNSSchedule One Update - Bacanora Lithium Plc
26th Jul 20167:00 amRNSDirectorate Change
18th Jul 20164:50 pmRNSSch 1 - Bacanora Lithium Plc
18th Jul 20167:00 amRNSPosting of Circular and Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.